RTA promoter demethylation and histone acetylation regulation of murine gammaherpesvirus 68 reactivation

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Yang, Zhangsheng ^a,b   Tang, Haidong ^a,b   Huang, Hai ^a,b   Deng, Hongyu ^a,c  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; HISTONE DEACETYLASE 3; HISTONE H3; HISTONE H4; REPLICATION AND TRANCRIPTION ACTIVATOR PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC TRANSCRIPTION; HERPES VIRUS; LATENT PERIOD; LATENT VIRUS INFECTION; MOUSE; MURINE GAMMAHERPESVIRUS 68; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SEQUENCE ANALYSIS; VIRION; VIRUS REACTIVATION;

MURINAE; MURINE HEPATITIS VIRUS;

EID: 84887212508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004556     Document Type: Article

References (68)

1. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD, et al. (1990) Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 71(Pt 6): 1365-1372
2. Efstathiou S, Ho YM, Minson AC (1990) Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol 71(Pt 6): 1355-1364.
3. Simas JP, Efstathiou S (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6: 276-282.
4. Nash AA, Dutia BM, Stewart JP, Davison AJ (2001) Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356: 569-579.
5. Speck SH, Virgin HW (1999) Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2: 403-409.
6. Stevenson PG, Efstathiou S (2005) Immune mechanisms in murine gamma-herpesvirus-68 infection. Viral Immunol 18: 445-456.
7. Virgin HW, Speck SH (1999) Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr Opin Immunol 11: 371-379.
8. Blackman MA, Flano E (2002) Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model? J Exp Med 195: F29-32.
9. Ragoczy T, Heston L, Miller G (1998) The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72: 7978-7984.
10. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866-10871.
11. Zalani S, Holley-Guthrie E, Kenney S (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 93: 9194-9199.
12. Lukac DM, Renne R, Kirshner JR, Ganem D (1998) Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252: 304-312.
13. Lukac DM, Kirshner JR, Ganem D (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348-9361.
14. Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R (2000) Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 74: 3659-3667.
15. Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, et al. (2000) Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 74: 6207-6212.
16. Geiman TM, Robertson KD (2002) Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together? J Cell Biochem 87: 117-125.
17. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080.
18. Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, et al. (2001) Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci U S A 98: 4119-4124.
19. Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, et al. (2003) Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol 77: 11425-11435.
20. Chang LK, Liu ST (2000) Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res 28: 3918-3925.
21. Countryman JK, Gradoville L, Miller G (2008) Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol 82: 4706-4719.
22. Ben-Sasson SA, Klein G (1981) Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. Int J Cancer 28: 131-135.
23. Moser JM, Upton JW, Gray KS, Speck SH (2005) Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. J Virol 79: 5227-5231.
24. Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, et al. (1999) Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A 96: 7508-7513.
25. Usherwood EJ, Stewart JP, Nash AA (1996) Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol 70: 6516-6518.
26. Kapoor A, Agius F, Zhu JK (2005) Preventing transcriptional gene silencing by active DNA demethylation. FEBS Lett 579: 5889-5898.
27. Sunil-Chandra NP, Efstathiou S, Nash AA (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73(Pt 12): 3275-3279.
28. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T (1998) Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187: 1941-1951.
29. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA (2000) Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165: 1074-1081.
30. Weck KE, Kim SS, Virgin HI, Speck SH (1999) B cells regulate murine gammaherpesvirus 68 latency. J Virol 73: 4651-4661.
31. Fenic I, Sonnack V, Failing K, Bergmann M, Steger K (2004) In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. J Androl 25: 811-818.
32. Attwood JT, Yung RL, Richardson BC (2002) DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 59: 241-257.
33. Singal R, Ginder GD (1999) DNA methylation. Blood 93: 4059-4070.
34. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
35. Esteller M (2005) DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol 17: 55-60.
36. Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM, Ambinder RF (2001) Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrob Agents Chemother 45: 2082-2091.
37. Tao Q, Robertson KD (2003) Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109: 53-63.
38. Moser JM, Upton JW, Allen RD 3rd, Wilson CB, Speck SH (2005) Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J Virol 79: 9480-9491.
39. Wolffe AP, Guschin D (2000) Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129: 102-122.
40. Knoepfler PS, Eisenman RN (1999) Sin meets NuRD and other tails of repression. Cell 99: 447-450.
41. Fog CK, Jensen KT, Lund AH (2007) Chromatin-modifying proteins in cancer. Apmis 115: 1060-1089.
42. Gronbaek K, Hother C, Jones PA (2007) Epigenetic changes in cancer. Apmis 115: 1039-1059.
43. Gibbons RJ (2005) Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet 14 Spec No 1: R85-92.
44. Wade PA (2001) Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 10: 693-698.
45. Seo JS, Cho NY, Kim HR, Tsurumi T, Jang YS, et al. (2008) Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. Oncol Rep 19: 93-98.
46. Cress WD, Seto E (2000) Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184: 1-16.
47. Ng HH, Bird A (2000) Histone deacetylases: silencers for hire. Trends Biochem Sci 25: 121-126.
48. Grozinger CM, Schreiber SL (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 9: 3-16.
49. Verdin E, Dequiedt F, Kasler HG (2003) Class II histone deacetylases: versatile regulators. Trends Genet 19: 286-293.
50. Yang WM, Tsai SC, Wen YD, Fejer G, Seto E (2002) Functional domains of histone deacetylase-3. J Biol Chem 277: 9447-9454.
51. Takami Y, Nakayama T (2000) N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line. J Biol Chem 275: 16191-16201.
52. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48.
53. Lechner T, Carrozza MJ, Yu Y, Grant PA, Eberharter A, et al. (2000) Sds3 (suppressor of defective silencing 3) is an integral component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity. J Biol Chem 275: 40961-40966.
54. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D (1997) Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89: 357-364.
55. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl: 245-254.
56. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874.
57. Adcock IM, Ford P, Ito K, Barnes PJ (2006) Epigenetics and airways disease. Respir Res 7: 21.
58. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935.
59. Sengupta N, Seto E (2004) Regulation of histone deacetylase activities. J Cell Biochem 93: 57-67.
60. Alland L, Muhle R, Hou H Jr, Potes J, Chin L, et al. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49-55.
61. Wen YD, Perissi V, Staszewski LM, Yang WM, Krones A, et al. (2000) The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A 97: 7202-7207.
62. Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101.
63. Gore SD, Baylin S, Sugar E, Carraway H, Miller CB, et al. (2006) Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res 66: 6361-6369.
64. Zhang Y, Fatima N, Dufau ML (2005) Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol 25: 7929-7939.
65. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, et al. (2005) Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol 19: 1740-1751.
66. Olek A, Oswald J, Walter J (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 24: 5064-5066.
67. Hajkova P, el-Maarri O, Engemann S, Oswald J, Olek A, et al. (2002) DNA-methylation analysis by the bisulfite-assisted genomic sequencing method. Methods Mol Biol 200: 143-154.
68. Spencer VA, Sun JM, Li L, Davie JR (2003) Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 31: 67-75.